Securian Asset Management Inc Has $1.85 Million Holdings in Waters Co. (NYSE:WAT)

Securian Asset Management Inc lessened its holdings in shares of Waters Co. (NYSE:WAT) by 1.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,355 shares of the medical instruments supplier’s stock after selling 100 shares during the quarter. Securian Asset Management Inc’s holdings in Waters were worth $1,851,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of WAT. BlackRock Inc. increased its holdings in Waters by 4.8% during the 1st quarter. BlackRock Inc. now owns 4,955,424 shares of the medical instruments supplier’s stock worth $1,408,183,000 after purchasing an additional 225,071 shares in the last quarter. Geode Capital Management LLC increased its holdings in Waters by 2.5% during the 1st quarter. Geode Capital Management LLC now owns 1,033,254 shares of the medical instruments supplier’s stock worth $293,103,000 after purchasing an additional 25,417 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in Waters by 9.5% during the 1st quarter. Champlain Investment Partners LLC now owns 987,075 shares of the medical instruments supplier’s stock worth $280,497,000 after purchasing an additional 85,275 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Waters by 30.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 435,843 shares of the medical instruments supplier’s stock worth $123,854,000 after purchasing an additional 101,061 shares in the last quarter. Finally, Marathon Asset Management LLP increased its holdings in Waters by 15.3% during the 2nd quarter. Marathon Asset Management LLP now owns 430,356 shares of the medical instruments supplier’s stock worth $148,721,000 after purchasing an additional 57,055 shares in the last quarter. 88.08% of the stock is currently owned by institutional investors and hedge funds.

Waters stock opened at $409.49 on Wednesday. Waters Co. has a 52 week low of $187.31 and a 52 week high of $428.22. The company has a debt-to-equity ratio of 5.98, a quick ratio of 1.89 and a current ratio of 2.41. The stock has a market capitalization of $25.13 billion, a P/E ratio of 38.70, a PEG ratio of 4.20 and a beta of 0.80. The stock has a 50-day simple moving average of $395.44 and a 200 day simple moving average of $338.04.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, August 3rd. The medical instruments supplier reported $2.60 EPS for the quarter, topping analysts’ consensus estimates of $2.29 by $0.31. The business had revenue of $681.70 million during the quarter, compared to analysts’ expectations of $625.36 million. Waters had a return on equity of 387.10% and a net margin of 24.73%. Waters’s quarterly revenue was up 31.1% on a year-over-year basis. During the same quarter last year, the company posted $2.10 earnings per share. Research analysts forecast that Waters Co. will post 10.66 earnings per share for the current year.

In other news, Director Thomas P. Salice sold 5,000 shares of Waters stock in a transaction that occurred on Thursday, August 5th. The shares were sold at an average price of $395.00, for a total value of $1,975,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Linda Baddour sold 1,260 shares of Waters stock in a transaction that occurred on Monday, August 16th. The shares were sold at an average price of $408.99, for a total transaction of $515,327.40. The disclosure for this sale can be found here. Insiders have sold 13,260 shares of company stock valued at $5,300,907 over the last 90 days. Company insiders own 1.10% of the company’s stock.

WAT has been the subject of several analyst reports. SVB Leerink raised their price objective on Waters from $370.00 to $385.00 and gave the company a “market perform” rating in a report on Wednesday, August 4th. Zacks Investment Research upgraded Waters from a “hold” rating to a “buy” rating and set a $418.00 price objective for the company in a report on Saturday, August 7th. Evercore ISI upgraded Waters from an “in-line” rating to an “outperform” rating and set a $400.00 price objective for the company in a report on Tuesday, July 6th. Citigroup raised their price objective on Waters from $315.00 to $400.00 and gave the company a “neutral” rating in a report on Wednesday, August 4th. Finally, Robert W. Baird raised their price objective on Waters from $297.00 to $360.00 and gave the company a “neutral” rating in a report on Wednesday, August 4th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $306.64.

Waters Profile

Waters Corp. is a specialty measurement company which engages in analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through the Waters and TA segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and related services.

Featured Story: The components of the Stochastic Momentum Index

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.